酰胺质子转移成像可检测胶质瘤分级与肿瘤增殖:与Ki-67表达及质子磁共振波谱成像的比较
前瞻性研究纳入42例未治疗的原发性脑胶质瘤患者(低级别28例、高级别14例),术前2周内于同一台3T扫描仪完成常规MRI、质子磁共振波谱成像和酰胺质子转移加权成像。结果显示3.5 ppm处的不对称磁化转移率在高级别胶质瘤中显著高于低级别胶质瘤,与肿瘤分级及Ki-67标记指数相关,并与胆碱、N-乙酰天冬氨酸等代谢物相关。作者认为3.5 ppm处的不对称磁化转移率可能作为评估增殖和预测组织病理学分级的潜在生物标志物。
要点
- 3.5 ppm处的不对称磁化转移率在高级别胶质瘤中显著高于低级别胶质瘤,阈值2.93%时敏感度92.9%、特异度71.4%。
- 3.5 ppm处的不对称磁化转移率与肿瘤分级(r=0.506,P=.0006)及Ki-67标记指数(r=0.502,P=.002)相关。
- 3.5 ppm处的不对称磁化转移率与胆碱(r=0.43,P=.009)及胆碱/N-乙酰天冬氨酸比值(r=0.42,P=.01)正相关,与N-乙酰天冬氨酸(r=-0.455,P=.005)负相关。
核心结论
- 3.5 ppm处的不对称磁化转移率可能作为评估胶质瘤增殖和预测组织病理学分级的潜在生物标志物。
研究设计与样本
- 前瞻性研究纳入42例未治疗的原发性脑胶质瘤患者,其中低级别28例、高级别14例,术前2周内于同一台3T扫描仪完成常规MRI、质子磁共振波谱成像和酰胺质子转移加权成像,以切除标本的组织病理学分级和Ki-67免疫组化表达为参考标准。
诊断标准与关键数值
- 3.5 ppm处的不对称磁化转移率鉴别高级别与低级别胶质瘤的阈值为2.93%,敏感度92.9%、特异度71.4%;高级别胶质瘤为3.61%±0.155,低级别胶质瘤为2.64%±0.185(P=.0016)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Prognosis in glioma depends strongly on tumor grade and proliferation. In this prospective study of patients with untreated primary cerebral gliomas, we investigated whether amide proton transfer-weighted imaging could reveal tumor proliferation and reliably distinguish low-grade from high-grade gliomas compared with Ki-67 expression and proton MR spectroscopy imaging.
MATERIALS AND METHODS: This study included 42 patients with low-grade (n = 28) or high-grade (n = 14) glioma, all of whom underwent conventional MR imaging, proton MR spectroscopy imaging, and amide proton transfer-weighted imaging on the same 3T scanner within 2 weeks before surgery. We assessed metabolites of choline and N-acetylaspartate from proton MR spectroscopy imaging and the asymmetric magnetization transfer ratio at 3.5 ppm from amide proton transfer-weighted imaging and compared them with histopathologic grade and immunohistochemical expression of the proliferation marker Ki-67 in the resected specimens.
RESULTS: The asymmetric magnetization transfer ratio at 3.5 ppm values measured by different readers showed good concordance and were significantly higher in high-grade gliomas than in low-grade gliomas (3.61% ± 0.155 versus 2.64% ± 0.185, P = .0016), with sensitivity and specificity values of 92.9% and 71.4%, respectively, at a cutoff value of 2.93%. The asymmetric magnetization transfer ratio at 3.5 ppm values correlated with tumor grade (r = 0.506, P = .0006) and Ki-67 labeling index (r = 0.502, P = .002). For all patients, the asymmetric magnetization transfer ratio at 3.5 ppm correlated positively with choline (r = 0.43, P = .009) and choline/N-acetylaspartate ratio (r = 0.42, P = .01) and negatively with N-acetylaspartate (r = -0.455, P = .005). These correlations held for patients with low-grade gliomas versus those with high-grade gliomas, but the correlation coefficients were higher in high-grade gliomas (choline: r = 0.547, P = .053; N-acetylaspartate: r = -0.644, P = .017; choline/N-acetylaspartate: r = 0.583, P = .036).
CONCLUSIONS: The asymmetric magnetization transfer ratio at 3.5 ppm may serve as a potential biomarker not only for assessing proliferation, but also for predicting histopathologic grades in gliomas.
引用
- Su C, Liu C, Zhao L, et al. Amide Proton Transfer Imaging Allows Detection of Glioma Grades and Tumor Proliferation: Comparison with Ki-67 Expression and Proton MR Spectroscopy Imaging. AJNR Am J Neuroradiol. 2017. PMID: 28729292. doi:10.3174/ajnr.A5301
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。